IBRUMART

Advanced Targeted Therapy for Leukemia, Lymphoma & Blood Disorders

IBRUMART is a prescription-based targeted anticancer medicine containing Ibrutinib, a Bruton’s Tyrosine Kinase (BTK) inhibitor indicated for the treatment of several B-cell malignancies. It is widely used in the management of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL), Waldenström’s Macroglobulinemia (WM), and other selected blood cancers as recommended by a specialist.

IBRUMART works by blocking the BTK protein, which plays a crucial role in the growth, survival, and spread of abnormal B-cells. By targeting this pathway, it helps slow disease progression, reduce the number of cancer cells, and improve long-term treatment outcomes. It is an oral targeted therapy prescribed as part of personalized oncology and hematology treatment plans.

Key Benefits of IBRUMART

• Contains Ibrutinib, a clinically proven BTK inhibitor
• Effective in treating Chronic Lymphocytic Leukemia (CLL)
• Used for Small Lymphocytic Lymphoma (SLL)
• Indicated for Mantle Cell Lymphoma (MCL)
• Helps manage Waldenström’s Macroglobulinemia (WM)
• Blocks the growth and spread of abnormal B-cells
• Convenient oral targeted therapy
• Supports long-term management of blood cancers
• Used under specialist hematology and oncology supervision

Uses of IBRUMART

IBRUMART is commonly prescribed for the treatment of:

• Chronic Lymphocytic Leukemia (CLL)
• Small Lymphocytic Lymphoma (SLL)
• Mantle Cell Lymphoma (MCL)
• Waldenström’s Macroglobulinemia (WM)
• Chronic Graft-versus-Host Disease (cGVHD), where indicated
• Other B-cell malignancies as advised by an oncologist or hematologist

Why Choose IBRUMART?

IBRUMART offers a precision medicine approach for treating blood cancers by targeting the underlying biological pathways responsible for cancer cell survival. It is widely trusted by hematologists and oncologists for its proven clinical effectiveness, oral administration, and role in improving outcomes for patients with leukemia and lymphoma.

Important Safety Information

• Prescription-only anticancer medicine.
• Use only under the supervision of a qualified hematologist or oncologist.
• Regular monitoring of blood counts, liver function, heart health, and overall clinical condition is recommended.
• Inform your doctor about any bleeding disorders, infections, heart disease, liver disease, or other medications before starting treatment.
• Do not discontinue therapy without consulting your healthcare provider.
• Keep out of reach of children.